FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10801811000001105: Lidocaine 4% oromucosal solution 4ml vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37141801000001116 Lidocaine 4% oromucosal solution 4ml vials 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
44866901000001110 Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes 1 pre-filled disposable injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Is pack of Lidocaine hydrochloride 40mg/mL(4%) sterile solution false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has VMP Lidocaine hydrochloride 40mg/mL(4%) sterile solution false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has VMP Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 1 vial Has VMP Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Laryngojet 4% oromucosal solution 4ml vials (UCB (Pharma) Ltd) 1 vial Is a True Lidocaine 4% oromucosal solution 4ml vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start